Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (428)	11/20/2003 11:56:41 PM
From: Jibacoa	Respond to of 3722

ESMC Is not a Biotech <g> (It makes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices.) In their 1stQ (Sep.)they reported a 140.5% gain in net income to $623K, or $0.154/share, compared with $259K, or $0.076/share the previous year. (This was accomplished on a 13.4% gain in revenues.) biz.yahoo.com The stock has had a good % gain from its January L around $0.85 (The November 5 H was $8.10 <g>)The present PE is around 12 Caveat: I have a small position on ESMC which I bought somewhat late (June )but can't complain about it. <g> There was an up-gap on September 28 which never got closed,and still may be of some concern, but the stock has managed to stay above that level.<g> bigcharts.marketwatch.com Bernard